Today's blog features the recently published Express Scripts article that takes a deeper look into the effectiveness of biosimilars. Biosimilars have the potential to offer clinical equivalents to some of the most expensive prescription drugs.
"Biosimilars are similar to generic drugs, providing alternatives to original biologic therapies which typically are injected and treat many of the most complex medical conditions, such as cancer, rare diseases and rheumatoid arthritis. They do not have clinically meaningful distinctions in safety, purity and potency from the original biologics."
The potential cost savings has shown to be very significant. ESI research has identified a $250 billion savings opportunity over the next decade if a group of 11 biosimilars are approved.
Learn about the most recent approvals and more information on this topic by clicking HERE!
Performance Pharmacy Solutions (PPS) is a unique pharmacy benefit procurement platform developed by HORIZON Health Ventures to efficiently and effectively place, manage and oversee our self-funded client's pharmacy benefit management programs. The PPS platform provides turnkey solutions with proven market-leading PBM partners that offer, on average, 10-15% savings.
Performance Pharmacy Solutions (PPS) is a unique pharmacy benefit procurement platform developed by HORIZON Health Ventures to efficiently and effectively place, manage and oversee our self-funded client's pharmacy benefit management programs. The PPS platform provides turnkey solutions with proven market-leading PBM partners that offer, on average, 10-15% savings.
No comments:
Post a Comment